Literature DB >> 28495464

MicroRNA-21 via Dysregulation of WW Domain-Containing Protein 1 Regulate Atrial Fibrosis in Atrial Fibrillation.

Hui Tao1, Meng Zhang1, Jing-Jing Yang2, Kai-Hu Shi3.   

Abstract

BACKGROUND: microRNAs (miRs) have been reported to regulate cell biological functions. To explore the underlying mechanism of miR-21 involvement in patients with atrial fibrosis and atrial fibrillation (AF).
METHODS: In total, 49 patients (24 AF, sinus rhythm 25) aged 33-68 years old, including heart valve replacement surgery and cardiac catheterisation. The pathological changes and collagen depositions was analysed by Masson's Trichrome Staining. miR-21, TGF-β1, Smad2, p-Smad2, WWP-1, collagen I and collagen III expression were analysed by Western blotting, qRT-PCR, miR one step qRT-PCR, respectively. Treatment human cardiac fibroblasts with TGF-β1, qRT-PCR and Western blotting to find changes in miR-21, Smad2 and WWP-1 levels. Transfected human cardiac fibroblasts with miR-21 mimic and miR-21 inhibitor. Finally, cell proliferation ability was assessed by the MTT assay and flow cytometry.
RESULTS: Compared to sinus rhythm (SR) group, the collagen volume fraction was significantly increased in AF patients. The levels of the TGF-β1, collagen I and collagen III were significantly elevated in AF group. In AF patients, the expression of miR-21 was increased, while the expression of WWP-1 was decreased. Transfected cardiac fibroblasts with miR-21 mimic increased miR-21 expression and decreased WWP-1 expression, whereas miR-21 inhibitor causes the opposite effects. Additionally, we demonstrated that knockdown miR-21 targeted up-regulation of WWP-1 may suppress cardiac fibroblasts proliferation.
CONCLUSION: These indicated that miR-21 inhibits cardiac fibroblasts proliferation by inactivating the TGF-β1/Smad2 signaling pathway via up-regulation of WWP-1.
Copyright © 2017 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atrial fibrosis; Cardiac fibroblast; MicroRNA-21; Smad 2; TGF-β1; WW domain-containing protein 1

Mesh:

Substances:

Year:  2017        PMID: 28495464     DOI: 10.1016/j.hlc.2016.01.022

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  10 in total

1.  MicroRNA expression signatures of atrial fibrillation: The critical systematic review and bioinformatics analysis.

Authors:  Nan-Nan Shen; Chi Zhang; Zheng Li; Ling-Cong Kong; Xin-Hua Wang; Zhi-Chun Gu; Jia-Liang Wang
Journal:  Exp Biol Med (Maywood)       Date:  2019-11-25

2.  Liraglutide inhibits AngII-induced cardiac fibroblast proliferation and ECM deposition through regulating miR-21/PTEN/PI3K pathway.

Authors:  Jun Wang; Run Guo; Xiaoli Ma; Ying Wang; Qianyu Zhang; Nan Zheng; Jun Zhang; Chenchen Li
Journal:  Cell Tissue Bank       Date:  2022-07-06       Impact factor: 1.522

3.  Identification of microRNAs enriched in exosomes in human pericardial fluid of patients with atrial fibrillation based on bioinformatic analysis.

Authors:  Langsha Liu; Yubin Chen; Jie Shu; Can-E Tang; Ying Jiang; Fanyan Luo
Journal:  J Thorac Dis       Date:  2020-10       Impact factor: 2.895

Review 4.  Exosomes and Exosomal Non-coding RNAs Are Novel Promises for the Mechanism-Based Diagnosis and Treatments of Atrial Fibrillation.

Authors:  Chaofeng Chen; Qingxing Chen; Kuan Cheng; Tian Zou; Yang Pang; Yunlong Ling; Ye Xu; Wenqing Zhu
Journal:  Front Cardiovasc Med       Date:  2021-12-01

5.  MiR-21-3p Inhibits Adipose Browning by Targeting FGFR1 and Aggravates Atrial Fibrosis in Diabetes.

Authors:  Jian-An Pan; Hao Lin; Jian-Ying Yu; Hui-Li Zhang; Jun-Feng Zhang; Chang-Qian Wang; Jun Gu
Journal:  Oxid Med Cell Longev       Date:  2021-08-25       Impact factor: 6.543

Review 6.  A narrative review of non-coding RNAs in atrial fibrillation: potential therapeutic targets and molecular mechanisms.

Authors:  Lan Zhang; Xi Wang; Congxin Huang
Journal:  Ann Transl Med       Date:  2021-09

Review 7.  Exosomes in atrial fibrillation: therapeutic potential and role as clinical biomarkers.

Authors:  Kun Xiang; Muhammad Akram; Walaa Fikry Elbossaty; Jinfu Yang; Chengming Fan
Journal:  Heart Fail Rev       Date:  2021-07-12       Impact factor: 4.654

Review 8.  Potential Clinical Implications of miR-1 and miR-21 in Heart Disease and Cardioprotection.

Authors:  Branislav Kura; Barbora Kalocayova; Yvan Devaux; Monika Bartekova
Journal:  Int J Mol Sci       Date:  2020-01-21       Impact factor: 5.923

Review 9.  E3 Ubiquitin ligase NEDD4 family‑regulatory network in cardiovascular disease.

Authors:  Ying Zhang; Hao Qian; Boquan Wu; Shilong You; Shaojun Wu; Saien Lu; Pingyuan Wang; Liu Cao; Naijin Zhang; Yingxian Sun
Journal:  Int J Biol Sci       Date:  2020-08-21       Impact factor: 6.580

Review 10.  Genetics and Epigenetics of Atrial Fibrillation.

Authors:  Estefanía Lozano-Velasco; Diego Franco; Amelia Aranega; Houria Daimi
Journal:  Int J Mol Sci       Date:  2020-08-10       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.